Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 19
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2028EMP1-008LncRNAHumanDownregulated in ICC (with log fold change of more than 2) Diagnostic and PrognosticICC v/s Normal; significantly downregulated in ICC with tumor metastasis p < 0.05Tissue28401021
2029ATF3-008LncRNAHumanDownregulated in ICC (with log fold change of more than 2) Diagnostic and PrognosticICC v/s Normal; significantly downregulated in ICC with tumor metastasis p < 0.05Tissue28401021
2030RCOR3-013LncRNAHumanDownregulated in ICC (with log fold change of more than 2) Diagnostic and PrognosticICC v/s Normal; significantly downregulated in ICC with tumor metastasis p < 0.05Tissue28401021
2044lncBRMLncRNAHumanUpregulated in HCC tumours and liver CSCs Diagnostic and PrognosticLiver CSCs (Cancer stem cells) and early and advanced HCC tumours p < 0.001Tissue27905400
2231TP73-AS1LncRNAHumanUpregulated in HCC (with more than 2 fold change) Diagnostic and PrognosticHCC v/s Normal; associated with worse clinicopathological features, poorer prognosis and shorter survival p < 0.001Tissue28403886
2232CCAT2LncRNAHumanUpregulated in HCC DiagnosticHCC v/s Normal p < 0.05Tissue27347113
2233UCA1LncRNAHumanUpregulated in HCC DiagnosticHCC v/s Normal p < 0.05Tissue28271214
2234CCAT2LncRNAHumanUpregulated in HCC PrognosticHCC v/s Normal; associated with poor survival in HCC patients p < 0.01Tissue28280353
2235SNHG20LncRNAHumanUpregulated in HCC PrognosticHCC v/s Normal; associated with survival of patients p < 0.001Tissue27053960
2236MALAT1LncRNAHuman, Mice and cell linesUpregulated in HCC with Fold change=3.233 DiagnosticHCC v/s Normal p < 0.05Tissue27993818
2237ANRILLncRNAHumanUpregulated in HCC with Fold change >1.0 DiagnosticHCC v/s Normal p < 0.01Tissue25966845
2238CCAT1LncRNAHumanUpregulated in HCC PrognosticHCC v/s Normal; correlated with tumor size, microvascular invasion and poor prognosis p < 0.001Tissue25884472
2239lncCAMTA1LncRNAHumanUpregulated in HCC and lncCAMTA1 is increased in HCC and indicates poor outcome. PrognosticHCC v/s Normal; associated with poor recurrence free survival and overall survival of patients p < 0.01Tissue27669232
2240lncRNA-hPVT1LncRNAHumanUpregulated in HCC and higher hPVT1 expression levels in HCC tissues significantly correlated with markedly reduced recurrence-free survival Diagnostic and PrognosticHCC v/s Normal; associated with recurrence and survival in patients p < 0.001Tissue25043274
2241DANCRLncRNAHumanUpregulated in HCC Diagnostic and PrognosticHCC v/s Normal/Cirrhosis/CHB;associated with metastasis of patients p < 0.001Plasma27919960
2242RP11-160H22.5LncRNAHumanUpregulated in HCC with Fold change >2.0 DiagnosticHCC v/s Normal p < 0.01Plasma25714016
2243XLOC_014172LncRNAHumanUpregulated in HCC with Fold change >2.1 Diagnostic and PrognosticHCC v/s Normal; associated with metastatsis of patients p < 0.01Plasma25714016
2244LOC149086LncRNAHumanUpregulated in HCC with Fold change >2.0 Diagnostic and PrognosticHCC v/s Normal; associated with metastatsis of patients p < 0.01Plasma25714016
2245RP11-160H22.5, XLOC_014172, LOC149086LncRNAHumanUpregulated in HCC with Fold change >2.0 Diagnostic and PrognosticHCC v/s Normal; associated with metastatsis of patients p < 0.01Plasma25714016

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top